| scholarly article | Q13442814 |
| P2093 | author name string | Anantharamaiah GM | |
| Garber DW | |||
| Kulkarni KR | |||
| P433 | issue | 6 | |
| P304 | page(s) | 1020-1026 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples | |
| P478 | volume | 41 |
| Q36352583 | 25(OH)D3 and cardiovascular risk factors in female nonhuman primates |
| Q34530236 | A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling |
| Q28538300 | A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism |
| Q28592410 | A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice |
| Q35994373 | A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients. |
| Q35654048 | A spontaneous mutation in Srebf2 leads to cataracts and persistent skin wounds in the lens opacity 13 (lop13) mouse |
| Q24658096 | Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II |
| Q42119788 | An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice |
| Q34731730 | Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. |
| Q34391565 | ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line |
| Q90068241 | ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters |
| Q37298363 | Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats |
| Q35622488 | Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing. |
| Q36496717 | Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis |
| Q35843366 | Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. |
| Q35395341 | Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice |
| Q35566496 | CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model |
| Q36593979 | Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndrome |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q48298889 | Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics. |
| Q37052240 | Effects of a Western-type diet on plasma lipids and other cardiometabolic risk factors in African green monkeys (Chlorocebus aethiops sabaeus). |
| Q34674336 | Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels |
| Q36447185 | HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats |
| Q37152209 | Hyphenating size-exclusion chromatography with electrospray mass spectrometry; using on-line liquid-liquid extraction to study the lipid composition of lipoprotein particles |
| Q51306832 | Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization. |
| Q35606800 | Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. |
| Q33762645 | Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis |
| Q35536385 | Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk |
| Q35995692 | Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice |
| Q38898464 | MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor |
| Q34980994 | Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production |
| Q37130807 | Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia |
| Q39234722 | Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays |
| Q58752719 | Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques |
| Q34608010 | Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing. |
| Q34287846 | Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice. |
| Q35944538 | Probucol therapy overcomes the reproductive defect in CTP: phosphocholine cytidylyltransferase beta2 knockout mice |
| Q24319027 | Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation |
| Q37133557 | Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse |
| Q36721513 | Significant genotype by diet (G × D) interaction effects on cardiometabolic responses to a pedigree-wide, dietary challenge in vervet monkeys (Chlorocebus aethiops sabaeus). |
| Q63915339 | TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice |
| Q37613222 | Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice |
| Q88958207 | Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr-/- mice |
| Q30535428 | Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. |
Search more.